Neurofibromatosis and Schwannoma CasesNeuroblastoma Research and TreatmentsNerve injury and regenerationDNA Repair MechanismsCancer, Hypoxia, and Metabolism
Publications
376
Citations
5,949
Est. group size
~3
Recurring co-author estimate
Active years
25
Publishing since 2002
Publication cadence
Publications per year over the last 10 years — averaging 50.0/year recently
Recent publications
- Structure-functionality relationship of collagen-fibrin interpenetrating hydrogels for engineered tumor-stroma models
Acta Biomaterialia · 2026
- Abstract 5348: Tumor remodeling pathways are enriched in the tumor microenvironment of obesity-associated colorectal cancer.
Cancer Research · 2026
- Aptamers in cancer therapy: Why has clinical translation lagged behind preclinical promise?
Biomedicine & Pharmacotherapy · 2026
- Ketogenic supplementation enhances KRASG12D inhibitor efficacy in pancreatic ductal adenocarcinoma
Cancer Letters · 2026
- Molecular and Clinical Profiling of Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs): An Analysis of the Oncology Research Information Exchange Network Database
Endocrine Abstracts · 2026
- Reply
Gastroenterology · 2026
- Correction: Cui et al. Anticancer Peptides Derived from Aldolase A and Induced Tumor-Suppressing Cells Inhibit Pancreatic Ductal Adenocarcinoma Cells. Pharmaceutics 2023, 15, 2447
Pharmaceutics · 2026
- Formulation effects on oral APE1/Ref1 inhibitors pharmacokinetics in mice
Drug Metabolism and Pharmacokinetics · 2025
- Timely administration of drug combination improves chemoimmunotherapy of an immune-cold tumor
Journal of Controlled Release · 2025
- Fast-Relaxing Hydrogels Promote Pancreatic Adenocarcinoma Cell Aggressiveness through Integrin β1 Signaling
Biomacromolecules · 2025
- Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors
Nature Communications · 2025
- Physics Informed Constrained Learning of Dynamics from Static Data
arXiv (Cornell University) · 2025
- Abstract 1167: Targeting DNA repair pathways in PDAC: APE1 BER and its therapeutic role in PDAC homeostasis
Cancer Research · 2025
- Abstract A120: Disrupting PAR-1-mediated protease signaling in the PDAC tumor and its microenvironment
Cancer Research · 2025
- Abstract B037: Validation and translation of therapeutic potential of thrombin-PAR1 signaling in suppressing fibrosis using microphysiological PDAC tumor models
Cancer Research · 2025
Publishes in
- Cancer Research×27
- Figshare×27
- bioRxiv (Cold Spring Harbor Laboratory)×8
- Molecular Cancer Therapeutics×6
- Oncotarget×4
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 9, 2026.
Claim or correct this profile